USD
+$0.00
(+0.00%
)At Close (As of Sep 26, 2025)
$7.48M
Market Cap
-
P/E Ratio
-11.97
EPS
$5.47
52 Week High
$0.96
52 Week Low
HEALTHCARE
Sector
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$16K |
Selling General And Administrative | $15K |
Research And Development | $904 |
Operating Expenses | $16K |
Investment Income Net | - |
Net Interest Income | $875 |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $49K |
Income Before Tax | -$16K |
Income Tax Expense | $0 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$16M |
Comprehensive Income Net Of Tax | - |
Ebit | -$65K |
Ebitda | -$16K |
Net Income | -$18M |
Field | Value (USD) |
---|---|
Total Assets | $85M |
Total Current Assets | $83M |
Cash And Cash Equivalents At Carrying Value | $163K |
Cash And Short Term Investments | $163K |
Inventory | - |
Current Net Receivables | - |
Total Non Current Assets | $1.9M |
Property Plant Equipment | - |
Accumulated Depreciation Amortization Ppe | - |
Intangible Assets | - |
Intangible Assets Excluding Goodwill | - |
Goodwill | $1.7M |
Investments | - |
Long Term Investments | - |
Short Term Investments | - |
Other Current Assets | $83M |
Other Non Current Assets | - |
Total Liabilities | $28M |
Total Current Liabilities | $28M |
Current Accounts Payable | $3M |
Deferred Revenue | - |
Current Debt | - |
Short Term Debt | $163K |
Total Non Current Liabilities | $59K |
Capital Lease Obligations | $141K |
Long Term Debt | - |
Current Long Term Debt | - |
Long Term Debt Noncurrent | - |
Short Long Term Debt Total | $141K |
Other Current Liabilities | $24M |
Other Non Current Liabilities | - |
Total Shareholder Equity | $58M |
Treasury Stock | - |
Retained Earnings | -$202M |
Common Stock | $475 |
Common Stock Shares Outstanding | $3.4M |
Field | Value (USD) |
---|---|
Operating Cashflow | -$9.2M |
Payments For Operating Activities | - |
Proceeds From Operating Activities | - |
Change In Operating Liabilities | - |
Change In Operating Assets | - |
Depreciation Depletion And Amortization | $49K |
Capital Expenditures | $0 |
Change In Receivables | - |
Change In Inventory | - |
Profit Loss | - |
Cashflow From Investment | $88K |
Cashflow From Financing | $5.6M |
Proceeds From Repayments Of Short Term Debt | - |
Payments For Repurchase Of Common Stock | - |
Payments For Repurchase Of Equity | - |
Payments For Repurchase Of Preferred Stock | - |
Dividend Payout | - |
Dividend Payout Common Stock | - |
Dividend Payout Preferred Stock | - |
Proceeds From Issuance Of Common Stock | - |
Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
Proceeds From Issuance Of Preferred Stock | - |
Proceeds From Repurchase Of Equity | - |
Proceeds From Sale Of Treasury Stock | - |
Change In Cash And Cash Equivalents | - |
Change In Exchange Rate | - |
Net Income | -$18M |
Field | Value (USD) |
---|---|
Gross Profit | - |
Total Revenue | $0 |
Cost Of Revenue | - |
Costof Goods And Services Sold | - |
Operating Income | -$16K |
Selling General And Administrative | $15K |
Research And Development | $904 |
Operating Expenses | $16K |
Investment Income Net | - |
Net Interest Income | $875 |
Interest Income | - |
Interest Expense | - |
Non Interest Income | - |
Other Non Operating Income | - |
Depreciation | - |
Depreciation And Amortization | $49K |
Income Before Tax | -$16K |
Income Tax Expense | $0 |
Interest And Debt Expense | - |
Net Income From Continuing Operations | -$16M |
Comprehensive Income Net Of Tax | - |
Ebit | -$65K |
Ebitda | -$16K |
Net Income | -$18M |
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Entero Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of targeted and orally delivered therapies for the treatment of patients with gastrointestinal diseases. The company is headquartered in Boca Raton, Florida.